-
Vloga statinov v preprečevanju srčno-žilnih bolezni = The role of statins in the prevention of cardiovascular diseasesReiner, Željko ; Tedeschi Reiner, EugeniaThe HMG-CoA reductase inhibitors, often referred to as the statins, are inhibitors of cholesterol synthesis in hepatocytes. They are specific, competitive inhibitors of the enzyme HMG-CoA reductase, ... which catalyses the first step in cholesterol synthesis - the conversion of HMG-CoA to mevalonate.As a result, hepatic LDL-receptor activity increases, leading to increased uptake of LDL and decreased plasma total and LDL cholesterol. Several secondary prevention studies (4S, CARE, LIPID) in the last decade haveclearly demonstrated that secondary prevention of coronary heart disease (CHD) with statins should be essential treatment because it signi ficantly reduces cardiovascular morbidity and mortality and is cost-effective. There isincreasing evidence, particularly from primary prevention studies (WOSCOP, AFCAPS/TexCAPS), that statins should be used in primary prevention of CHD as well, especially for high risk patients. The greater is the total and LDL cholesterol reduction, the better is the risk lowering effect. However, the beneficial effects of statins should not only be attributed to their cholesterol-lowering effects. They also reduce the enhanced susceptibility to oxidation of LDL particles, restore endothelial dysfunction, prevent arterial smooth muscle cell migration and proliferation, reduce platelet aggregation, improve impaired fibrinolysis and stabilize the plaque. Apart from these antiatherogenic effects they seem to increase bone formation, thus possibly reducing the risk of osteoporotic fractures, and may inhibit tumour cell growth as well.Vir: Krka v medicini in farmaciji. - ISSN 0351-6040 (23, [št.] 33, 2002, str. 19-32)Vrsta gradiva - članek, sestavni delLeto - 2002Jezik - slovenskiCOBISS.SI-ID - 17815001
Avtor
Reiner, Željko |
Tedeschi Reiner, Eugenia
Teme
Cardiovascular Diseases |
Prevention And Control |
Coronary Disease |
Hypercholesterolemia |
Hmg-Coa Reductase Inhibitors |
Clinical Trials |
Hiperholesterolemija |
Kardiovaskularne bolezni |
Koronarna bolezen |
Klinične raziskave |
kardiovaskularne bolezni |
koronarna bolezen |
preventivna medicina |
statini
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Reiner, Željko | |
Tedeschi Reiner, Eugenia |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi